NON SMALL CELL LUNG CANCER (SQUAMOUS OR NON SQUAMOUS)
Clinical trials for NON SMALL CELL LUNG CANCER (SQUAMOUS OR NON SQUAMOUS) explained in plain language.
Never miss a new study
Get alerted when new NON SMALL CELL LUNG CANCER (SQUAMOUS OR NON SQUAMOUS) trials appear
Sign up with your email to follow new studies for NON SMALL CELL LUNG CANCER (SQUAMOUS OR NON SQUAMOUS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for stage 4 lung cancer? experimental combo enters late-stage trial
Disease control Not yet recruitingThis study tests whether adding an experimental drug called EIK1001 to standard immunotherapy (pembrolizumab) and chemotherapy helps people with stage 4 non-small cell lung cancer live longer or slow tumor growth. About 750 adults whose cancer has spread will receive either the n…
Matched conditions: NON SMALL CELL LUNG CANCER (SQUAMOUS OR NON SQUAMOUS)
Phase: PHASE2, PHASE3 • Sponsor: Eikon Therapeutics • Aim: Disease control
Last updated May 04, 2026 16:30 UTC
-
Blood test may spare some lung cancer patients from chemo
Disease control Not yet recruitingThis study tests whether a simple blood test can identify people with advanced lung cancer who can be treated effectively with immunotherapy alone, avoiding chemotherapy. It includes 275 adults whose tumors have high PD-L1 levels and a low inflammation score (PTI=0). The goal is …
Matched conditions: NON SMALL CELL LUNG CANCER (SQUAMOUS OR NON SQUAMOUS)
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated May 04, 2026 16:23 UTC